1. A pharmacist may dispense a self-administered hormonal contraceptive under the protocol established pursuant to NRS 639.28077 to a patient, regardless of whether the patient has obtained a prescription from a practitioner. 2. A pharmacist must provide the risk assessment questionnaire prescribed by the Board pursuant to NRS 639.28077 to a patient who requests a self-administered hormonal contraceptive before dispensing the self-administered hormonal contraceptive to the patient. If the patient completes the questionnaire and the results of the questionnaire indicate that it is unsafe to dispense the self-administered hormonal contraceptive to the patient, the pharmacist: (a) Must not dispense the self-administered hormonal contraceptive; and (b) Must refer the patient to the patients attending provider or another qualified provider of health care. 3. A pharmacist who dispenses a self-administered hormonal contraceptive under the protocol shall: (a) Create a record concerning the dispensing of the self-administered hormonal contraceptive which includes, without limitation, the name of the patient to whom the self-administered hormonal contraceptive was dispensed, the type of self-administered hormonal contraceptive dispensed and any other relevant information required by the protocol prescribed pursuant to NRS 639.28077 . The pharmacist or his or her employer shall maintain the record for the amount of time prescribed in that protocol. (b) Inform the patient to whom the self-administered hormonal contraceptive is dispensed concerning: (1) Proper administration and storage of the self-administered hormonal contraceptive; (2) Potential side effects of the self-administered hormonal contraceptive; and (3) The need to use other methods of contraception, if appropriate. (c) Provide to the patient to whom the self-administered hormonal contraceptive is dispensed: (1) The written record required by subsection 4; and (2) Any written information required by the regulations adopted pursuant to NRS 639.28077 . (d) Comply with the regulations adopted pursuant to NRS 639.28077 and any guidelines for dispensing the self-administered hormonal contraceptive recommended by the manufacturer. 4. A pharmacist shall provide to any patient who requests a self-administered hormonal contraceptive under the protocol a written record of the request, regardless of whether the self-administered hormonal contraceptive is dispensed. The record must include, without limitation: (a) A copy of the risk assessment questionnaire if completed by the patient pursuant to subsection 2; and (b) A written record of the self-administered hormonal contraceptive requested and any self-administered hormonal contraceptive dispensed. 5. Any pharmacy that wishes to dispense self-administered hormonal contraceptives under the protocol must notify the Board of that fact. The Board shall post on an Internet website maintained by the Board a list of the names, addresses and contact information of pharmacies that have provided such notice. 6. As used in this section: (a) Attending provider means a provider of health care who provides or has provided care to the patient. (b) Provider of health care has the meaning ascribed to it in NRS 629.031 .
‹ Prev All Nevada sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.